Panagora Asset Management Inc Aravive, Inc. Transaction History

Panagora Asset Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$5.11 - $9.24 $1,313 - $2,374	-257 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$4.36 - $6.51 $41,441 - $61,877	-9,505 Reduced 97.37%	257 $1,000
Q3 2020 Nov 13, 2020	BUY	$4.7 - $12.06 $1,207 - $3,099	257 Added 2.7%	9,762 $46,000
Q2 2020 Aug 12, 2020	BUY	$5.18 - $14.81 $47,728 - $136,459	9,214 Added 3166.32%	9,505 $111,000
Q1 2020 May 14, 2020	SELL	$3.5 - $13.77 $1,067 - $4,199	-305 Reduced 51.17%	291 $2,000
Q3 2019 Nov 12, 2019	SELL	$5.2 - $8.68 $33,857 - $56,515	-6,511 Reduced 91.61%	596 $4,000
Q2 2019 Aug 09, 2019	SELL	$5.65 - $7.5 $576 - $765	-102 Reduced 1.41%	7,107 $43,000
Q1 2019 May 15, 2019	BUY	$3.35 - $8.27 $4,522 - $11,164	1,350 Added 23.04%	7,209 $51,000
Q4 2018 Feb 14, 2019	SELL	$3.23 - $8.7 $36,020 - $97,022	-11,152 Reduced 65.56%	5,859 $21,000
Q3 2018 Nov 13, 2018	BUY	$8.4 - $12.6 $142,892 - $214,338	17,011 New	17,011 $24,000

28.1K

Ticker ARAV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,518,300
Description
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.